T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$1.76B |
| 2 |
Eli Lilly
LLY
|
+$1.4B |
| 3 |
Bank of America
BAC
|
+$1.3B |
| 4 |
Tesla
TSLA
|
+$1.19B |
| 5 |
Wells Fargo
WFC
|
+$784M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$6.47B |
| 2 |
Amazon
AMZN
|
+$3.71B |
| 3 |
Yum! Brands
YUM
|
+$2.84B |
| 4 |
Salesforce
CRM
|
+$2.77B |
| 5 |
Fortive
FTV
|
+$2.41B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.07% |
| 2 | Healthcare | 18.73% |
| 3 | Consumer Discretionary | 14.62% |
| 4 | Financials | 10.39% |
| 5 | Communication Services | 9.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
EBIX
1926
DELISTED
Ebix Inc
EBIX
| $730K | ﹤0.01% |
38,412
+3,685
| +11% | +$81.1K |
|
1927
Laureate Education
LAUR
$5.1B
| $726K | ﹤0.01% |
68,746
+10,533
| +18% | +$119K |
|
1928
Brinker International
EAT
$10.2B
| $724K | ﹤0.01% |
28,967
-6,534
| -18% | -$176K |
|
1929
SiTime
SITM
$20.7B
| $724K | ﹤0.01% |
9,190
-57,168
| -86% | -$7.36M |
|
1930
Verra Mobility
VRRM
$731M
| $722K | ﹤0.01% |
46,953
+9,109
| +24% | +$148K |
|
1931
Bumble
BMBL
$359M
| $720K | ﹤0.01% |
33,483
-2,168,238
| -98% | -$64.1M |
|
|
LTC
1932
LTC Properties
LTC
$2.1B
| $719K | ﹤0.01% |
19,182
-14,618
| -43% | -$609K |
|
1933
InterDigital
IDCC
$8.88B
| $717K | ﹤0.01% |
17,717
+1,808
| +11% | +$97.5K |
|
1934
Bread Financial
BFH
$4.46B
| $714K | ﹤0.01% |
22,683
-1,101
| -5% | -$43.1K |
|
1935
Ligand Pharmaceuticals
LGND
$5.76B
| $713K | ﹤0.01% |
13,268
+2,058
| +18% | +$121K |
|
1936
Materion
MTRN
$5.9B
| $712K | ﹤0.01% |
8,899
+1,344
| +18% | +$111K |
|
1937
Krystal Biotech
KRYS
$9.72B
| $711K | ﹤0.01% |
10,194
+3,218
| +46% | +$232K |
|
1938
Forward Air
FWRD
$682M
| $710K | ﹤0.01% |
7,866
+1,797
| +30% | +$176K |
|
1939
Kyndryl
KD
$3.04B
| $708K | ﹤0.01% |
85,462
+24,336
| +40% | +$253K |
|
1940
Shake Shack
SHAK
$2.94B
| $708K | ﹤0.01% |
15,729
+3,029
| +24% | +$145K |
|
1941
Graham Holdings Company
GHC
$5.03B
| $704K | ﹤0.01% |
1,307
-981
| -43% | -$561K |
|
|
SILK
1942
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
| $701K | ﹤0.01% |
15,573
+2,254
| +17% | +$96.9K |
|
1943
3D Systems Corp
DDD
$601M
| $700K | ﹤0.01% |
87,678
+5,696
| +7% | +$58.5K |
|
1944
Enterprise Financial Services Corp
EFSC
$2.41B
| $700K | ﹤0.01% |
15,883
+3,723
| +31% | +$169K |
|
1945
CarGurus
CARG
$3.29B
| $698K | ﹤0.01% |
49,204
+12,265
| +33% | +$249K |
|
1946
Kearny Financial
KRNY
$604M
| $697K | ﹤0.01% |
65,579
-6,746,608
| -99% | -$77.6M |
|
1947
Brookfield Renewable
BEPC
$6.5B
| $696K | ﹤0.01% |
21,280
+13,571
| +176% | +$522K |
|
|
PDM
1948
Piedmont Realty Trust
PDM
$1.19B
| $696K | ﹤0.01% |
65,900
+10,489
| +19% | +$132K |
|
1949
MillerKnoll
MLKN
$1.64B
| $695K | ﹤0.01% |
44,493
-1,991
| -4% | -$54.7K |
|
|
VGR
1950
DELISTED
Vector Group Ltd.
VGR
| $694K | ﹤0.01% |
78,728
+1,547
| +2% | +$15.7K |
|
Similar funds
T. Rowe Price Associates's Q3 2022 Portfolio in Review
As of Q3 2022, T. Rowe Price Associates held 3,114 positions worth $610B, down 23% from $791B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
T. Rowe Price Associates withdrew a net $168B in Q3 2022, closing 171 positions and reducing 1,248 holdings. Its most notable exit was Alcon, an estimated $1.51B position sold in full.
By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, T. Rowe Price Associates opened a new position in Corebridge Financial worth $194M.
- T. Rowe Price Associates's largest Q3 2022 buy was Corebridge Financial: 9,831,688 shares worth $194M.
- T. Rowe Price Associates added most to ExxonMobil in Q3 2022, an estimated $1.76B increase.
- T. Rowe Price Associates's biggest Q3 2022 reduction was Microsoft, cutting an estimated $6.47B.
- T. Rowe Price Associates fully exited Alcon in Q3 2022, selling an estimated $1.51B.
- T. Rowe Price Associates's ten largest holdings make up 31% of its $610B portfolio in Q3 2022.
- T. Rowe Price Associates opened 154 new positions and closed 171 in Q3 2022.
- T. Rowe Price Associates's portfolio value fell 23% quarter-over-quarter to $610B.
Based on T. Rowe Price Associates's 13F filing for Q3 2022, filed 14 Nov 2022.